You could be reading the full-text of this article now if you...

If you have access to this article through your institution,
you can view this article in

Fertility preservation and reproductive health in the pediatric, adolescent, and young adult female cancer patient

Trudgen, Kourtneya; Ayensu-Coker, Leslieb

Current Opinion in Obstetrics & Gynecology:
doi: 10.1097/GCO.0000000000000107
ADOLESCENT AND PEDIATRIC GYNECOLOGY: Edited by Paula J. Adams Hillard
Abstract

Purpose of review: As treatments for malignancies become increasingly successful, emphasis on quality of life in survivorship becomes important. Of equal importance is the role of gonadotoxic agents in the management of chronic medical conditions, such as nonmalignant blood disorders and rheumatologic and genetic conditions. Gonadotoxic agents have long-term effects to include ovarian insufficiency, pubertal arrest and subsequent infertility.

Recent findings: In 2004, ovarian tissue cryopreservation emerged as an investigational but viable option for prepubertal patients and those unable to undergo ovarian stimulation. In 2012, oocyte preservation became standard therapy for patients without a partner or who elected not to use donor sperm or freeze embryos. Ovarian reserve testing with antimullerian hormone to assess fertility after gonadotoxic therapy is a rapidly growing area of interest with potentially significant benefits in personalizing the approach to fertility preservation.

Summary: A systematic approach to fertility preservation prior to treatment in all patients receiving gonadotoxic agents optimizes care. Fertility preservation strategies can restore hormonal function and preserve reproductive potential. Future research in personalizing approach to care is critical to meeting the needs of this patient population.

Author Information

aUniversity of Kentucky College of Medicine

bDivision of Gynecologic Subspecialties, Department of Obstetrics and Gynecology, University of Kentucky College of Medicine, Lexington, Kentucky, USA

Correspondence to Leslie Ayensu-Coker, MD, Division of Gynecologic Subspecialties, Department of Obstetrics and Gynecology, UK Healthcare, University of Kentucky College of Medicine, 800 Rose Street Room C358, Lexington, KY 40536, USA. Fax: +1 859 257 6886; e-mail: leslie.appiah@uky.edu

© 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins